Font size: Normal | Large | X-Large
 

Clinical Trials

Treatment of retinal diseases is a rapidly changing field of medicine with new techniques and procedures being developed every year. Southwest Retina Specialists has been involved with research over the last four years for a variety of retina conditions, including diabetic macular edema and age-related macular degeneration.

While clinical trials are always voluntary, to qualify a patient would go through a screening process to determine eligibility that varies from study to study.

Please contact our study coordinator, Ashley Villegas, at 806-351-1870 (ext. 1113) if you are interested in being screened or want more information on a clinical trial being conducted.

You can learn more about each trail and how to participate in a clinical trial at:
http://www.ClinicalTrials.gov
http://www.fda.gov

Current Studies Open for Enrollment of patients:

WET MACULAR DEGENERATION (Actively Recruiting)

  • OPH-1006 - An 18 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer) To evaluate the safety of intravitreal (IVT) Fovista® administered in combination with anti-VEGF therapy.
    • ClinicalTrials.gov Identifier: NCT02387957
    • Sponsor: Ophthotech Corporation.
    • Site: Southwest Retina Specialist, Amarillo, TX.
  • OPH-1004 - A Phase 3 Safety and Efficacy Study of Fovista™ (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy.
    • ClinicalTrials.gov Identifier: NCT01940887
    • Sponsor: Ophthotech Corporation.
    • Site: Southwest Retina Specialist, Amarillo, TX

DIABETIC RETINOPATHY (Actively Recruiting)

  • Phase II Combination Steroid and Anti-VEGF for Persistent DME (Protocol U).
    • ClinicalTrials.gov Identifier: NCT01945866
    • Sponsor: Diabetic Retinopathy Clinical Research Network
    • Site: Southwest Retina Specialist, Amarillo, TX
  • Treatment for CI-DME in Eyes with Very Good VA Study (Protocol V).
    • ClinicalTrials.gov Identifier: NCT01909791
    • Sponsor: Diabetic Retinopathy Clinical Research Network
    • Site: Southwest Retina Specialist, Amarillo, TX

  • Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME (Protocol T).
    ClinicalTrials.gov Identifier: NCT01627249
    Sponsor: Diabetic Retinopathy Clinical Research Network
    Site: Southwest Retina Specialist, Amarillo, TX